EUCR

Eucrates Biomedical Acquisition Corp. Ordinary Shares
EUCR

Delisted

EUCR was delisted on the 26th of April, 2023.

Back to rankings

38 hedge funds and large institutions have $84.5M invested in Eucrates Biomedical Acquisition Corp. Ordinary Shares in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 4 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more first-time investments, than exits

New positions opened: | Existing positions closed:

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

Holders
38
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$6.98M
2
+$3.75M
3
+$562K
4
FTCM
First Trust Capital Management
Illinois
+$388K
5
MSU
Mizuho Securities USA
New York
+$192K

Top Sellers

1
-$3.07M
2
-$990K
3
-$430K
4
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$367K
5
Goldman Sachs
Goldman Sachs
New York
-$251K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$10.2M
2
$10M
3
$9.02M
4
$6.68M
5
$6.53M
6
$6.01M
7
$4.38M
8
$4.01M
9
$3.69M
10
$2.71M
11
$2.09M
12
$2M
13
$2M
14
$1.79M
15
$1.6M
16
$1.56M
17
$1.41M
18
$1.19M
19
$1.09M
20
$1.03M
21
$1M
22
$802K
23
$741K
24
$719K
25
$562K
1
2